Burrill on Biotech - BioPharm International


Burrill on Biotech

Biotech on a Roll to Start 2010

April 1, 2010

As the capital markets in the US and globally continue to strengthen, the biotech industry can expect to see a rise in initial public offerings this year.

Biotech Remains Upbeat During the Summer

October 1, 2009

Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.

Biotech Shows Glimmer of an Upward Trend

July 1, 2009

Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.

Biotech Industry Reports a Profit but Many Companies Still Struggle for Survival

April 1, 2009

Big biotechs will do just fine in the ongoing financial crisis, but the smaller companies will have more difficulty weathering the storm.

Small-Cap Biotech Companies Conserve Cash to Ride Out The Prevailing Economic Conditions

January 1, 2009

Small biotechs were forced to restructure and downsize.

Will The Biotech Industry Survive The Financial Crisis?

December 1, 2008

The meltdown in the financial markets represents a sea change in the world of financing that will continue to affect the flow of much needed capital into the sector for the foreseeable future.

Biotech Cruises On Despite a Turbulent Economic Climate

October 1, 2008

The biotech industry's year-to-date report card contains good grades despite the turbulent economic climate.

Biotech Survives Difficult Opening to 2008

June 1, 2008

Following the market crisis of the first quarter of 2008, biotech IPOs and financing are down, but partnering continues, and mergers and acquisitions (M&As) remain hot.

What Lies Ahead for Biotech in 2008

March 1, 2008

Despite the rising fears about a slowing economy, the biotech industry will continue to maintain its momentum this year.



Click here